Application of machine-learning algorithms for better understanding of tableting properties of lactose co-processed with lipid excipients

Co-processing (CP) provides superior properties to excipients and has become a reliable option to facilitated formulation and manufacturing of variety of solid dosage forms. Development of directly compressible formulations with high doses of poorly flowing/compressible active pharmaceutical ingredients, such as paracetamol, remains a great challenge for the pharmaceutical industry due to the lack of understanding of the interplay between the formulation properties, process of compaction, and stages of tablets’ detachment and ejection. The aim of this study was to analyze the influence of the compression load, excipients’ co-processing and the addition of paracetamol on the obtained tablets’ tensile strength and the specific parameters of the tableting process, such as (net) compression work, elastic recovery, detachment, and ejection work, as well as the ejection force. Two types of neural networks were used to analyze the data: classification (Kohonen network) and regression networks (multilayer perceptron and radial basis function), to build prediction models and identify the variables that are predominantly affecting the tableting process and the obtained tablets’ tensile strength. It has been demonstrated that sophisticated data-mining methods are necessary to interpret complex phenomena regarding the effect of co-processing on tableting properties of directly compressible excipients

Pregled primene algoritama mašinskog učenja u farmaceutskoj tehnologiji

Machine learning algorithms, and artificial intelligence in general, have a wide range of applications in the field of pharmaceutical technology. Starting from the formulation development, through a great potential for integration within the Quality by design framework, these data science tools provide a better understanding of the pharmaceutical formulations and respective processing. Machine learning algorithms can be especially helpful with the analysis of the large volume of data generated by the Process analytical technologies. This paper provides a brief explanation of the artificial neural networks, as one of the most frequently used machine learning algorithms. The process of the network training and testing is described and accompanied with illustrative examples of machine learning tools applied in the context of pharmaceutical formulation development and related technologies, as well as an overview of the future trends. Recently published studies on more sophisticated methods, such as deep neural networks and light gradient boosting machine algorithm, have been described. The interested reader is also referred to several official documents (guidelines) that pave the way for a more structured representation of the machine learning models in their prospective submissions to the regulatory bodies.Algoritmi mašinskog učenja, kao i veštačka inteligencija u širem smislu, su veoma značajni i primenjuju se u razne svrhe u okviru farmaceutske tehnologije. Počevši od razvoja formulacija, preko izuzetnog potencijala za integraciju u koncept dizajna kvaliteta (engl. Quality by design), algoritmi mašinskog učenja omogućavaju bolje razumevanje uticaja kako formulacionih faktora tako i odgovarajućih procesnih parametara. Algoritmi mašinskog učenja mogu biti od naročitog značaja i za analizu velikog obima podataka koji se generišu korišćenjem procesnih analitičkih tehnologija. U ovom radu su ukratko predstavljene veštačke neuronske mreže, kao jedan od najčešće korišćenih algoritama mašinskog učenja. Prikazani su procesi treninga i testiranja mreža, kao i ilustrativni primeri algoritama primenjenih za različite potrebe razvoja i/ili optimizacije farmaceutskih formulacija i postupaka njihove izrade. Takođe, dat je i pregled budućih trendova u ovoj oblasti, kao i novijih studija o sofisticiranim metodama, poput dubokih neuronskih mreža, i light gradient boosting algoritma. Zainteresovani čitaoci se takođe upućuju na nekoliko zvaničnih dokumenata (vodiča), po uzoru na koje mogu da se očekuju i preporuke za strukturiranu prezentaciju modela mašinskog učenja koji će se podnositi regulatornim telima u okviru dokumentacije koja se priprema za potrebe registracije novih lekova

Disrupting 3D printing of medicines with machine learning.

3D printing (3DP) is a progressive technology capable of transforming pharmaceutical development. However, despite its promising advantages, its transition into clinical settings remains slow. To make the vital leap to mainstream clinical practice and improve patient care, 3DP must harness modern technologies. Machine learning (ML), an influential branch of artificial intelligence, may be a key partner for 3DP. Together, 3DP and ML can utilise intelligence based on human learning to accelerate drug product development, ensure stringent quality control (QC), and inspire innovative dosage-form design. With ML's capabilities, streamlined 3DP drug delivery could mark the next era of personalised medicine. This review details how ML can be applied to elevate the 3DP of pharmaceuticals and importantly, how it can expedite 3DP's integration into mainstream healthcare

Machine learning models for the prediction of pharmaceutical powder properties

Error on title page – year of award is 2023.Understanding how particle attributes affect the pharmaceutical manufacturing process performance remains a significant challenge for the industry, adding cost and time to the development of robust products and production routes. Tablet formation can be achieved by several techniques however, direct compression (DC) and granulation are the most widely used in industrial operations. DC is of particular interest as it offers lower-cost manufacturing and a streamlined process with fewer steps compared with other unit operations. However, to achieve the full potential benefits of DC for tablet manufacture, this places strict demands on material flow properties, blend uniformity, compactability, and lubrication, which need to be satisfied. DC is increasingly the preferred technique for pharmaceutical companies for oral solid dose manufacture, consequently making the flow prediction of pharmaceutical materials of increasing importance. Bulk properties are influenced by particle attributes, such as particle size and shape, which are defined during crystallization and/or milling processes. Currently, the suitability of raw materials and/or formulated blends for DC requires detailed characterization of the bulk properties. A key goal of digital design and Industry 4.0 concepts is through digital transformation of existing development steps be able to better predict properties whilst minimizing the amount of material and resources required to inform process selection during early- stage development. The work presented in Chapter 4 focuses on developing machine learning (ML) models to predict powder flow behaviour of routine, widely available pharmaceutical materials. Several datasets comprising powder attributes (particle size, shape, surface area, surface energy, and bulk density) and flow properties (flow function coefficient) have been built, for pure compounds, binary mixtures, and multicomponent formulations. Using these datasets, different ML models, including traditional ML (random forest, support vector machines, k nearest neighbour, gradient boosting, AdaBoost, Naïve Bayes, and logistic regression) classification and regression approaches, have been explored for the prediction of flow properties, via flow function coefficient. The models have been evaluated using multiple sampling methods and validated using external datasets, showing a performance over 80%, which is sufficiently high for their implementation to improve manufacturing efficiency. Finally, interpretability methods, namely SHAP (SHapley Additive exPlanaitions), have been used to understand the predictions of the machine learning models by determining how much each variable included in the training dataset has contributed to each final prediction. Chapter 5 expanded on the work presented in Chapter 4 by demonstrating the applicability of ML models for the classification of the viability of pharmaceutical formulations for continuous DC via flow function coefficient on their powder flow. More than 100 formulations were included in this model and the particle size and particle shape of the active pharmaceutical ingredients (APIs), the flow function coefficient of the APIs, and the concentration of the components of the formulations were used to build the training dataset. The ML models were evaluated using different sampling techniques, such as bootstrap sampling and 10-fold cross-validation, achieving a precision of 90%. Furthermore, Chapter 6 presents the comparison of two data-driven model approaches to predict powder flow: a Random Forest (RF) model and a Convolutional Neural Network (CNN) model. A total of 98 powders covering a wide range of particle sizes and shapes were assessed using static image analysis. The RF model was trained on the tabular data (particle size, aspect ratio, and circularity descriptors), and the CNN model was trained on the composite images. Both datasets were extracted from the same characterisation instrument. The data were split into training, testing, and validation sets. The results of the validation were used to compare the performance of the two approaches. The results revealed that both algorithms achieved a similar performance since the RF model and the CNN model achieved the same accuracy of 55%. Finally, other particle and bulk properties, i.e., bulk density, surface area, and surface energy, and their impact on the manufacturability and bioavailability of the drug product are explored in Chapter 7. The bulk density models achieved a high performance of 82%, the surface area models achieved a performance of 80%, and finally, the surface-energy models achieved a performance of 60%. The results of the models presented in this chapter pave the way to unified guidelines moving towards end-to-end continuous manufacturing by linking the manufacturability requirements and the bioavailability requirements.Understanding how particle attributes affect the pharmaceutical manufacturing process performance remains a significant challenge for the industry, adding cost and time to the development of robust products and production routes. Tablet formation can be achieved by several techniques however, direct compression (DC) and granulation are the most widely used in industrial operations. DC is of particular interest as it offers lower-cost manufacturing and a streamlined process with fewer steps compared with other unit operations. However, to achieve the full potential benefits of DC for tablet manufacture, this places strict demands on material flow properties, blend uniformity, compactability, and lubrication, which need to be satisfied. DC is increasingly the preferred technique for pharmaceutical companies for oral solid dose manufacture, consequently making the flow prediction of pharmaceutical materials of increasing importance. Bulk properties are influenced by particle attributes, such as particle size and shape, which are defined during crystallization and/or milling processes. Currently, the suitability of raw materials and/or formulated blends for DC requires detailed characterization of the bulk properties. A key goal of digital design and Industry 4.0 concepts is through digital transformation of existing development steps be able to better predict properties whilst minimizing the amount of material and resources required to inform process selection during early- stage development. The work presented in Chapter 4 focuses on developing machine learning (ML) models to predict powder flow behaviour of routine, widely available pharmaceutical materials. Several datasets comprising powder attributes (particle size, shape, surface area, surface energy, and bulk density) and flow properties (flow function coefficient) have been built, for pure compounds, binary mixtures, and multicomponent formulations. Using these datasets, different ML models, including traditional ML (random forest, support vector machines, k nearest neighbour, gradient boosting, AdaBoost, Naïve Bayes, and logistic regression) classification and regression approaches, have been explored for the prediction of flow properties, via flow function coefficient. The models have been evaluated using multiple sampling methods and validated using external datasets, showing a performance over 80%, which is sufficiently high for their implementation to improve manufacturing efficiency. Finally, interpretability methods, namely SHAP (SHapley Additive exPlanaitions), have been used to understand the predictions of the machine learning models by determining how much each variable included in the training dataset has contributed to each final prediction. Chapter 5 expanded on the work presented in Chapter 4 by demonstrating the applicability of ML models for the classification of the viability of pharmaceutical formulations for continuous DC via flow function coefficient on their powder flow. More than 100 formulations were included in this model and the particle size and particle shape of the active pharmaceutical ingredients (APIs), the flow function coefficient of the APIs, and the concentration of the components of the formulations were used to build the training dataset. The ML models were evaluated using different sampling techniques, such as bootstrap sampling and 10-fold cross-validation, achieving a precision of 90%. Furthermore, Chapter 6 presents the comparison of two data-driven model approaches to predict powder flow: a Random Forest (RF) model and a Convolutional Neural Network (CNN) model. A total of 98 powders covering a wide range of particle sizes and shapes were assessed using static image analysis. The RF model was trained on the tabular data (particle size, aspect ratio, and circularity descriptors), and the CNN model was trained on the composite images. Both datasets were extracted from the same characterisation instrument. The data were split into training, testing, and validation sets. The results of the validation were used to compare the performance of the two approaches. The results revealed that both algorithms achieved a similar performance since the RF model and the CNN model achieved the same accuracy of 55%. Finally, other particle and bulk properties, i.e., bulk density, surface area, and surface energy, and their impact on the manufacturability and bioavailability of the drug product are explored in Chapter 7. The bulk density models achieved a high performance of 82%, the surface area models achieved a performance of 80%, and finally, the surface-energy models achieved a performance of 60%. The results of the models presented in this chapter pave the way to unified guidelines moving towards end-to-end continuous manufacturing by linking the manufacturability requirements and the bioavailability requirements